Sirtuins are crucial regulators of T cell metabolism and functions

참고문헌 (136)

1. Nicholson, L. B., "The immune system", Essays Biochem, 60, pp.275~301 (2016)
2. Chaplin, D. D., "1. Overview of the immune response", J. Allergy Clin. Immunol, 111, pp.S442~S459 (2003)
3. Luckheeram, R. V., "CD4(+)T cells : differentiation and functions", Clin. Dev. Immunol, 2012, pp.925135~ (2012)
4. Russell, J. H., "Lymphocyte-mediated cytotoxicity", Annu. Rev. Immunol, 20, pp.323~370 (2002)
5. Spellberg, B., "Type 1", Type 2 immunity in infectious diseases, 2001, pp.32, 76~102
6. Del Prete, G., "Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy", Allergy, 47, pp.450~455 (1992)
7. Neurath, M. F., "Th9 cells in immunity and immunopathological diseases", Semin. Immunopathol, 39, pp.1~4 (2017)
8. Annunziato, F., "Phenotypic and functional features of human Th17 cells", J. Exp. Med, 204, pp.1849~1861 (2007)
9. Rudensky, A. Y., "Regulatory T cells and Foxp3", Immunol. Rev, 241, pp.260~268 (2011)
10. Chen, W., "Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3", J. Exp. Med, 198, pp.1875~1886 (2003)
11. Chang, C. H., "Posttranscriptional control of T cell effector function by aerobic glycolysis", Cell, 153, pp.1239~1251 (2013)
12. Ho, P. C., "Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses", Cell, 162, pp.1217~1228 (2015)
13. Lunt, S. Y., "Aerobic glycolysis: meeting the metabolic requirements of cell proliferation", Annu. Rev. Cell Dev. Biol, 27, pp.441~464 (2011)
14. Carr, E. L., "Glutamine uptake and metabolism are coordinately regulated by ERK", MAPK during T lymphocyte activation, 2010, pp.185, 1037~1044
15. Wang, R., "The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation", Immunity, 35, pp.871~882 (2011)
16. Pearce, E. L., "Fueling immunity : insights into metabolism and lymphocyte function", Science, 342, pp.1242454~ (2013)
17. Wahl, D. R., "Distinct metabolic programs in activated T cells : opportunities for selective immunomodulation", Immunol. Rev, 249, pp.104~115 (2012)
18. Klysz, D., "Glutamine-dependent alpha-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation", Sci. Signal, 8, pp.ra97~ (2015)
19. Pacella, I., "Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth", Proc. Natl Acad. Sci. Usa, 115, pp.E6546~E6555 (2018)
20. Raud, B., "Fatty acid metabolism in CD8(+)T cell memory : Challenging current concepts", Immunol. Rev, 283, pp.213~231 (2018)
21. Raud, B., "Etomoxir actions on regulatory and memory T cells are independent of Cpt1a-mediated fatty acid oxidation", Cell Metab, 28, pp.504~515.e507 (2018)
22. Chang, C. H., "Metabolic competition in the tumor microenvironment is a driver of cancer progression", Cell, 162, pp.1229~1241 (2015)
23. Zhang, Y., "Enhancing CD8(+) T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy", Cancer Cell, 32, pp.377~391.e379 (2017)
24. Romanowska, J., "From genotype to phenotype : through chromatin", Genes(Basel), 10, pp.76~ (2019)
25. Chisolm, D. A., "Connections between metabolism and epigenetics in programming cellular differentiation", Annu. Rev. Immunol, 36, pp.221~246 (2018)
26. Margueron, R., "Chromatin structure and the inheritance of epigenetic information", Nat. Rev. Genet, 11, pp.285~296 (2010)
27. Yang, X., "Gene body methylation can alter gene expression and is a therapeutic target in cancer", Cancer Cell, 26, pp.577~590 (2014)
28. Wei, J. W., "Non-coding RNAs as regulators in epigenetics(Review)", Oncol. Rep, 37, pp.3~9 (2017)
29. Shahbazian, M. D., "Functions of site-specific histone acetylation and deacetylation", Annu. Rev. Biochem, 76, pp.75~100 (2007)
30. Bannister, A. J., "Regulation of chromatin by histone modifications", Cell Res, 21, pp.381~395 (2011)
31. Olsen, J. V., "Status of large-scale analysis of post-translational modifications by mass spectrometry", Mol. Cell. Proteom, 12, pp.3444~3452 (2013)
32. Aebersold, R., "How many human proteoforms are there?", Nat. Chem. Biol, 14, pp.206~214 (2018)
33. Prabakaran, S., "Post-translational modification : nature’s escape from genetic imprisonment and the basis for dynamic information encoding", Wiley Interdiscip. Rev. Syst. Biol. Med, 4, pp.565~583 (2012)
34. Bodenmiller, B., "Phosphoproteomic analysis reveals interconnected systemwide responses to perturbations of kinases and phosphatases in yeast", Sci. Signal, 3, pp.rs4~ (2010)
35. Wagner, S. A., "Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues", Mol. Cell Proteom, 11, pp.1578~1585 (2012)
36. Wang, Y., "Post-translational modifications of deubiquitinating enzymes: expanding the ubiquitin code", Front. Pharmacol, 12, pp.685011~ (2021)
37. Glozak, M. A., "Acetylation and deacetylation of non-histone proteins", Gene, 363, pp.15~23 (2005)
38. Zhao, S., "Regulation of cellular metabolism by protein lysine acetylation", Science, 327, pp.1000~1004 (2010)
39. Seto, E., "Erasers of histone acetylation : the histone deacetylase enzymes", Cold Spring Harb. Perspect. Biol, 6, pp.a018713~ (2014)
40. North, B. J., "Sirtuins : Sir2-related NAD-dependent protein deacetylases", Genome Biol, 5, pp.224~ (2004)
41. Michishita, E., "Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins", Mol. Biol. Cell, 16, pp.4623~4635 (2005)
42. Guarente, L., "Epstein Lecture: Sirtuins, aging, and medicine", N. Engl. J. Med, 364, pp.2235~2244 (2011)
43. Houtkooper, R. H., "Sirtuins as regulators of metabolism and healthspan", Nat. Rev. Mol. cell Biol, 13, pp.225~238 (2012)
44. Tanno, M., "Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1", J. Biol. Chem, 282, pp.6823~6832 (2007)
45. Vaquero, A., "SirT2 is a histone deacetylase with preference for histone H4Lys 16 during mitosis", Genes Dev, 20, pp.1256~1261 (2006)
46. Verdin, E., "Sirtuin regulation of mitochondria : energy production, apoptosis, and signaling", Trends Biochem. Sci, 35, pp.669~675 (2010)
47. Hawse, W. F., "Structure-based mechanism of ADP-ribosylation by sirtuins", J. Biol. Chem, 284, pp.33654~33661 (2009)
48. Du, J., "Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase", Science, 334, pp.806~809 (2011)
49. Kaeberlein, M., "The SIR2", 3, Genes Dev, pp.1999, 13[DOI]
50. Haigis, M. C., "Mammalian sirtuins–emerging roles in physiology, aging, and calorie restriction", Genes Dev, 20, pp.2913~2921 (2006)
51. Vachharajani, V. T., "Sirtuins link inflammation and metabolism", J. Immunol. Res, 2016, pp.8167273~ (2016)
52. Guarente, L., "Sirtuins as potential targets for metabolic syndrome", Nature, 444, pp.868~874 (2006)
53. Sebastian, C., "The role of mammalian sirtuins in cancer metabolism", Semin. Cell Dev. Biol, 43, pp.33~42 (2015)
54. Anderson, K. A., "Metabolic control by sirtuins and other enzymes that sense NAD(+), NADH, or their ratio", Biochim. Biophys. Acta Bioenerg, 1858, pp.991~998 (2017)
55. Newsholme, P., "Cellular and metabolic mechanisms of nutrient actions in immune function", Nutr. Diabetes, 11, pp.22~ (2021)
56. Mendes, K. L., "Nuclear sirtuins and inflammatory signaling pathways", Cytokine Growth Factor Rev, 38, pp.98~105 (2017)
57. Warren, J. L., "Regulation of adaptive immune cells by sirtuins", Front. Endocrinol. (Lausanne), 10, pp.466~ (2019)
58. Qiu, Y., "The role of sirtuin-1 in immune response and systemic lupus erythematosus", Front. Immunol, 12, pp.632383~ (2021)
59. Xi Chen, "Intercellular interplay between Sirt1 signalling and cell metabolism in immune cell biology", Immunology, 145(4), pp.455~467 (2015), Wiley[DOI]
60. Atsaves, V., "AP-1 Transcription factors as regulators of immune responses in cancer", Cancers(Basel), 11, pp.1037~ (2019)
61. Zhang, J., "The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice", J. Clin. Invest, 119, pp.3048~3058 (2009)
62. Zou, T., "Resveratrol Inhibits CD4+ T cell activation by enhancing the expression and activity of Sirt1", PLoS ONE, 8, pp.e75139~ (2013)
63. Chen, X., "Artesunate promotes Th1differentiation from CD4+ T cells to enhance cell apoptosis in ovarian cancer via miR-142", Braz. J. Med. Biol. Res, 52, pp.e7992~ (2019)
64. Sequeira, J., "sirt1-null mice develop an autoimmune-like condition", Exp. Cell Res, 314, pp.3069~3074 (2008)
65. Gao, B., "Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance", Proc. Natl Acad. Sci. USA, 109, pp.899~904 (2012)
66. McPherson, J. P., "Essential role for Bclaf1 in lung development and immune system function", Cell Death Differ, 16, pp.331~339 (2009)
67. Kong, S., "The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation", J. Biol. Chem, 286, pp.16967~16975 (2011)
68. Kim, S. R., "Involvement of sirtuin 1 in airway inflammation and hyperresponsiveness of allergic airway disease", J. Allergy Clin. Immunol, 125, pp.449~460.e414 (2010)
69. Legutko, A., "Sirtuin 1 promotes Th2 responses and airway allergy by repressing peroxisome proliferator-activated receptor-gamma activity in dendritic cells", J. Immunol, 187, pp.4517~4529 (2011)
70. Lorentsen, K. J., "Bcl11b is essential for licensing Th2 differentiation during helminth infection and allergic asthma", Nat. Commun, 9, pp.1679~ (2018)
71. Senawong, T., "Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor(COUP-TF)-interacting protein 2-mediated transcriptional repression", J. Biol. Chem, 278, pp.43041~43050 (2003)
72. Imtiyaz, H. Z., "Hypoxia-inducible factors as essential regulators of inflammation", Curr. Top. Microbiol. Immunol, 345, pp.105~120 (2010)
73. Wang, Y., "Histone deacetylase SIRT1 negatively regulates the differentiation of interleukin-9-producing CD4(+)T cells", Immunity, 44, pp.1337~1349 (2016)
74. Limagne, E., "Sirtuin-1 activation controls tumor growth by impeding Th17differentiation via STAT3 deacetylation", Cell Rep, 19, pp.746~759 (2017)
75. Wang, J., "Treatment with NAD(+)inhibited experimental autoimmune encephalomyelitis by activating AMPK", SIRT1 signaling pathway and modulating Th1, Int. Immunopharmacol, pp.2016, 39[DOI]
76. Wang, J., "Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK", SIRT1 signaling pathway and Th17, J. Neuroimmunol, pp.2016, 299[DOI]
77. Lim, H. W., "SIRT1 deacetylates RORgammat and enhances Th17 cell generation", J. Exp. Med, 212, pp.973~ (2015)
78. Kwon, H. S., "Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells", J. Immunol, 188, pp.2712~2721 (2012)
79. van Loosdregt, J., "Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization", Blood, 115, pp.965~974 (2010)
80. Marcel, N., "The lysine deacetylase Sirtuin 1 modulates the localization and function of the Notch1 receptor in regulatory T cells", Sci. Signal, 10, pp.eaah4679~ (2017)
81. Betz, B. C., "Batf coordinates multiple aspects of B and T cell function required for normal antibody responses", J. Exp. Med, 207, pp.933~942 (2010)
82. Kuroda, S., "Basic leucine zipper transcription factor, ATF-like(BATF)regulates epigenetically and energetically effector CD8 T-cell differentiation via Sirt1 expression", Proc. Natl Acad. Sci. USA, 108, pp.14885~14889 (2011)
83. Vega, R. B., "The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes", Mol. Cell. Biol, 20, pp.1868~1876 (2000)
84. Canto, C., "PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure", Curr. Opin. Lipidol, 20, pp.98~105 (2009)
85. Kelly, T. J., "GCN5-mediated transcriptional control of the metabolic coactivator PGC-1beta through lysine acetylation", J. Biol. Chem, 284, pp.19945~19952 (2009)
86. Jeng, M. Y., "Metabolic reprogramming of human CD8(+) memory T cells through loss of SIRT1", J. Exp. Med, 215, pp.51~62 (2018)
87. Rothgiesser, K. M., "SIRT2regulates NF-kappaB dependent gene expression through deacetylation of p65Lys310", J. Cell. Sci, 123, pp.4251~4258 (2010)
88. Lo Sasso, G., "SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis", PLoS One, 9, pp.e103573~ (2014)
89. Hamaidi, I., "Sirt2 Inhibition enhances metabolic fitness and effector functions of tumor-reactive T cells", Cell Metab, 32, pp.420~436.e12 (2020)
90. Zhang, J., "Mitochondrial Sirtuin 3 : new emerging biological function and therapeutic target", Theranostics, 10, pp.8315~8342 (2020)
91. Toubai, T., "Mitochondrial deacetylase SIRT3 plays an important role in donor T cell responses after experimental allogeneic hematopoietic transplantation", J. Immunol, 201, pp.3443~3455 (2018)
92. Ciarlo, E., "Sirtuin 3 deficiency does not alter host defenses against bacterial and fungal infections", Sci. Rep, 7, pp.3853~ (2017)
93. Beier, U. H., "Essential role of mitochondrial energy metabolism in Foxp3(+)T-regulatory cell function and allograft survival", Faseb. J, 29, pp.2315~2326 (2015)
94. Haigis, M. C., "SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells", Cell, 126, pp.941~954 (2006)
95. Johnson, M. O., "Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism", Cell, 175, pp.1780~1795.e1719 (2018)
96. Tao, J., "Mitochondrial Sirtuin 4 resolves immune tolerance in monocytes by rebalancing glycolysis and glucose oxidation homeostasis", Front. Immunol, 9, pp.419~ (2018)
97. Lin, W., "Sirtuin4 suppresses the antineuroinflammatory activity of infiltrating regulatory T cells in the traumatically injured spinal cord", Immunology, 158, pp.362~374 (2019)
98. Yang, X., "SIRT5, functions in cellular metabolism with a multiple enzymatic activities", Sci. China Life Sci, 58, pp.912~914 (2015)
99. Tannahill, G. M., "Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha", Nature, 496, pp.238~242 (2013)
100. Wang, F., "SIRT5 Desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1beta production and to prevent DSS-induced colitis in mice", Cell Rep, 19, pp.2331~2344 (2017)
101. Qin, K., "NAD(+)dependent deacetylase Sirtuin 5 rescues the innate inflammatory response of endotoxin tolerant macrophages by promoting acetylation of p65", J. Autoimmun, 81, pp.120~129 (2017)
102. Wang, K., "SIRT5 Contributes to colorectal cancer growth by regulating T cell activity", J. Immunol. Res, 2020, pp.3792409~ (2020)
103. Heinonen, T., "Sirtuin 5 deficiency does not compromise innate immune responses to bacterial infections", Front. Immunol, 9, pp.2675~ (2018)
104. Chang, A. R., "SIRT6, a mammalian deacylase with multitasking abilities", Physiol. Rev, 100, pp.145~169 (2020)
105. Jiang, H., "SIRT6 regulates TNF-alpha secretion through hydrolysis of longchain fatty acyl lysine", Nature, 496, pp.110~113 (2013)
106. Yeung, F., "Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase", EMBO J, 23, pp.2369~2380 (2004)
107. Kawahara, T. L., "SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaBdependent gene expression and organismal life span", Cell, 136, pp.62~74 (2009)
108. Xiao, C., "Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice", J. Biol. Chem, 287, pp.41903~41913 (2012)
109. Bauer, I., "The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+responses", J. Biol. Chem, 287, pp.40924~40937 (2012)
110. Van Gool, F., "Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner", Nat. Med, 15, pp.206~210 (2009)
111. Bruzzone, S., "Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE", PLoS ONE, 4, pp.e7897~ (2009)
112. Montecucco, F., "Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction", Antioxid. Redox Signal, 18, pp.630~641 (2013)
113. Krzywinska, E., "Hypoxia, metabolism and immune cell function", Biomedicines, 6, pp.56~ (2018)
114. Dang, E. V., "Control of T(H)17", T(reg)balance by hypoxia-inducible factor 1, 2011, pp.146, 772~784
115. Shi, L. Z., "HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells", J. Exp. Med, 208, pp.1367~1376 (2011)
116. Kim, H. S., "Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis", Cell Metab, 12, pp.224~236 (2010)
117. Zhong, L., "The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha", Cell, 140, pp.280~293 (2010)
118. Sebastian, C., "The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism", Cell, 151, pp.1185~1199 (2012)
119. Chen, S., "Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7", Mol. Cell, 52, pp.303~313 (2013)
120. Kiran, S., "Sirtuin 7 in cell proliferation, stress and disease: rise of the seventh Sirtuin!", Cell Signal, 27, pp.673~682 (2015)
121. Paredes, S., "Molecular pathways : emerging roles of mammalian Sirtuin SIRT7 in cancer", Clin. Cancer Res, 20, pp.1741~1746 (2014)
122. Blank, M. F., "The seven faces of SIRT7", Transcription, 8, pp.67~74 (2017)
123. Vakhrusheva, O., "Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice", Circ. Res, 102, pp.703~710 (2008)
124. Gao, X., "Immunomodulatory activity of resveratrol : suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production", Biochem. Pharmacol, 62, pp.1299~1308 (2001)
125. Gianchecchi, E., "Insights on the effects of resveratrol and some of its derivatives in cancer and autoimmunity : a molecule with a dual activity", Antioxidants(Basel), 9, pp.91~ (2020)
126. Xuzhu, G., "Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function", Ann. Rheum. Dis, 71, pp.129~135 (2012)
127. Lee, S. M., "Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes", Diabetologia, 54, pp.1136~1146 (2011)
128. Wang, B., "Regulatory effects of resveratrol on glucose metabolism and T-lymphocyte subsets in the development of high-fat diet-induced obesity in C57BL", 6 mice, 2014, pp.5, 1452~1463
129. Beier, U. H., "Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival", Mol. Cell Biol, 31, pp.1022~1029 (2011)
130. Levine, M. H., "Targeting Sirtuin-1 prolongs murine renal allograft survival and function", Kidney Int, 89, pp.1016~1026 (2016)
131. Ye, Q., "Sirtinol regulates the balance of Th17", Treg to prevent allograft rejection, 2017, pp.7, 55~
132. Chalkiadaki, A., "The multifaceted functions of sirtuins in cancer", Nat. Rev. Cancer, 15, pp.608~624 (2015)
133. Rosenberg, S. A., "Adoptive cell transfer as personalized immunotherapy for human cancer", Science, 348, pp.62~68 (2015)
134. Lim, W. A., "The principles of engineering immune cells to treat cancer", Cell, 168, pp.724~740 (2017)
135. Shevchenko, I., "Metabolic checkpoints : novel avenues for immunotherapy of cancer", Front. Immunol, 9, pp.1816~ (2018)
136. Gemta, L. F., "Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8(+) T cells", Sci. Immunol, 4, pp.eaap9520~ (2019)

관련 논문AI추천